Attached files
Exhibit
23.1
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM
We hereby consent to the incorporation by reference in the
Registration Statements on Form S-1 (File Nos. 333-235768 and
333-252087), Form S-8 (File No. 333-220781) and Form S-3 (File
Nos. 333-226065, 333-231035, 333-231954, 333-240129 and
333-252623) of our report dated March 31, 2021, related to the
consolidated financial statements of AzurRx BioPharma, Inc. as of
December 31, 2020 and 2019 and for the years then ended, which
appears in the Annual Report on Form 10-K of AzurRx BioPharma, Inc.
for the year ended December 31, 2020. Our report on the
consolidated financial statements of AzurRx BioPharma, Inc.
includes an explanatory paragraph about the existence of
substantial doubt concerning its ability to continue as a going
concern.
/s/ Mazars USA
LLP
New York, New
York
March 31,
2021